ADIPOQ and synovial sarcoma: In a clinical study of 98 SS patients and 165 healthy volunteers, three Wnt/β-catenin signaling pathway-related genes, LRP5, FRZB, and ADIPOQ, were shown to increase the risk of SS, although the biological functions of these genes have not yet been established (91).